NIH/National Institute of Allergy and Infectious Diseases

Diseases, Conditions, Syndromes

Lung autopsies of COVID-19 patients reveal treatment clues

Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of how the SARS-CoV-2 virus spreads and damages lung tissue. Scientists at the National Institutes of Health and their collaborators ...

Diseases, Conditions, Syndromes

Long-term study of children with COVID-19 begins

A large, long-term study of the impacts of COVID-19 on children has enrolled its first participant at the National Institutes of Health's Clinical Center in Bethesda, Maryland. The study, which is supported by the National ...

Diseases, Conditions, Syndromes

Exploring a key to hepatitis C entry into cells

In a new paper published in Nature, scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, describe the structure of a key protein on the surface of the ...

Diseases, Conditions, Syndromes

Monoclonal antibody prevents malaria in small NIH trial

One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in people who were exposed to the malaria parasite. The small, carefully monitored ...

Diseases, Conditions, Syndromes

Investigational malaria vaccine gives strong, lasting protection

Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites. ...

page 6 from 40